Significant Contract Modifications ($10M+) — July 07, 2026

A firm-fixed-price definitive contract with $118.9 million already outlayed signals strong execution and cash flow for this small business manufacturer, winning under full and open competition against larger rivals.

SAFESOURCE DIRECT LLC is a small business with a single large contract representing its entire revenue stream ($48.3M annual est.), creating extreme concentration risk if the contract is not extended beyond December 2026.

HHS/ASPR's industrial base expansion program is subject to annual appropriations and potential shifts in pandemic preparedness priorities, which could reduce follow-on funding.

SAFESOURCE DIRECT LLC could leverage this contract win to secure follow-on awards or expand into other HHS/ASPR industrial base programs for critical medical materials, given its proven execution and competitive win against larger firms.

HHS/ASPR's $144.8M award to SAFESOURCE DIRECT LLC for NBR production underscores sustained government investment in onshoring critical medical material manufacturing, reducing reliance on foreign suppliers.

{"entity"=>"SAFESOURCE DIRECT LLC", "reason"=>"Single-contract concentration with $118.9M already outlayed; revenue cliff risk at December 2026 expiration.", "trigger"=>"Any announcement of follow-on contract, option exercise, or re-compete for NBR production by HHS/ASPR"}

{"entity"=>"HHS/ASPR Industrial Base Expansion Program", "reason"=>"This contract is a bellwether for broader government spending on domestic medical supply chains.", "trigger"=>"FY2027 budget request, new solicitations for similar materials, or changes in pandemic preparedness policy"}